HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe

New HHS Surety Bond Rule Adds to HME Provider Headaches

July 1, 2007 by HME Business

HHS announced a proposed rule that would require DMEPOS to post a $65,000 surety bond as a condition of Medicare participation.

Intended to reduce fraud by increasing the cost of entry into the business, the bond was originally required by the 1997 Balanced Budget Act, although that legislation specified a slightly less expensive $50,000 bond. CMS’ predecessor, the Health Care Financing Administration, issued a proposed rule concerning the bond requirement in 1998, but it was never finalized.

Industry response ranged from dismay, especially given the onslaught of changes shaking the industry, from reimbursement cuts and oxygen cutbacks to competitive bidding and accreditation, to resignation. While some providers said the bond requirement is reasonable and worthwhile if it strengthens the industry’s reputation, others worry that it may be the final push that will convince many smaller providers to walk away from the business.

The bond is expected to cost suppliers $3,000 to $6,000 a year, which will add to the burden of increasing gasoline prices, vehicle insurance and utilities. Some providers expressed exasperation, saying that their expenses go up while reimbursements remain constant or decline.

The industry has until Oct. 1 to take a look at the proposed rule and submit comments. The complete text is available here:
http://a257.g.akamaitech.net/7/257/2422/01jan20071800/edocket.access.gpo.gov/2007/07-3746.htm.

Related Articles Read More >

Temporary Restraining Order Reinstates BOC as Accrediting Organization
The reinstatement is effective Jan. 9, 2025.
Fisher & Paykel’s F&P Nova Nasal Mask Now Available in US
The new mask is designed to support easy fitting and sound sleep for sleep apnea patients.
‘Common Sense’ Home Infusion Reform Discussed at Congressional Subcommittee Hearing
NHIA CEO Connie Sullivan urged House members to support the Preserving Patient Access to Home Infusion Act.
AAHomecare CEO to Congressional Subcommittee: ‘We Believe 37% of the Industry Has Gone Out of Business’
Tom Ryan testified about three durable medical equipment bills on Jan. 8.

Get the free newsletter

Home Healthcare Softare

Subscribe to HME Business for industry & product news, trends and resources.
HME Business Directory
HME Podcasts
HME Business
  • Mobility Management
  • Senior Housing News
  • Home Health Care News
  • Skilled Nursing News
  • Hospice News
  • Behavioral Health Business
  • About HME Business
  • Contact Us

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search HME Business

  • Home
  • Topics
    • COVID-19
    • Accreditation
    • Competitive Bidding
    • DME Pharmacy
    • Legislative
    • Mobility
    • Oxygen
    • Pain Management
    • Retail
    • Sales and Marketing
    • Sleep Therapy
    • Software/IT
  • News
  • Resources
    • Whitepapers
    • Buyers Guide
    • DME Associations
  • Podcasts
  • Request Media Kit
  • Webinars
  • Digital Edition
  • Events
  • Awards
  • Advertise
  • Subscribe